Why do Finland and Sweden differ when it comes to trends in asthma medication and hospitalisation for children aged 0-4 years?
- 1 August 2020
- journal article
- editorial
- Published by Wiley in Acta Paediatrica
- Vol. 109 (8), 1512-1513
- https://doi.org/10.1111/apa.15302
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The use of short-acting beta-2 adrenergic receptor agonists for asthma increased among Finnish and Swedish children from 2006 to 2017Acta Paediatrica, 2020
- Very low asthma death incidence among Finnish children from 1999 to 2015Pediatric Pulmonology, 2018
- Trends in paediatric asthma hospitalisations – differences between neighbouring countriesThorax, 2017
- Salbutamol with metered dose inhalers with spacers - an established emergency treatment for preschool wheezeActa Paediatrica, 2012
- Asthma mortality among Swedish children and young adults, a 10-year studyRespiratory Medicine, 2008
- Asthma hospitalizations continue to decrease in schoolchildren but hospitalization rates for wheezing illnesses remain high in young childrenActa Paediatrica, 2002
- Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in the prevalence of asthmaJournal of Allergy and Clinical Immunology, 1996